Literature DB >> 8533638

[A study on the rhodopsin gene in Japanese retinitis pigmentosa--screening of mutation by restriction endonucreases and frequencies of DNA polymorphisms].

H Kawano1, Y Hotta, K Fujiki, M Takeda, F Iwata, H Sakuma, M Hayakawa, A Kanai, T Shiono, M Tamai.   

Abstract

We analyzed 11 sites of the rhodopsin gene using polymerase chain reaction (PCR) amplification and restriction endonucleases in 30 unrelated Japanese patients with autosomal dominant retinitis pigmentosa (ADRP). No point mutation was found in any patient. The frequencies of the single nucleotide (nt) substitution at nt 269, nt 5145 and nt 5321 were examined in three groups, 38 unrelated patients with ADRP, 23 patients with autosomal recessive retinitis pigmentosa (ARRP), and 67 normal controls. There was no significant difference in the frequencies of substitution among these three groups. The frequencies of A269G, G5145A, and C5321A were 52%, 36%, and 5%, respectively. These values were different from those of the American population. The polymorphisms, A269G and G5145A, are useful as DNA makers for linkage analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533638

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  Rhodopsin mutations in Chinese patients with retinitis pigmentosa.

Authors:  W M Chan; K Y Yeung; C P Pang; L Baum; T C Lau; A K Kwok; D S Lam
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  Spectrum of rhodopsin mutations in Korean patients with retinitis pigmentosa.

Authors:  Kwang Joong Kim; Cinoo Kim; Jeong Bok; Kyung-Seon Kim; Eun-Ju Lee; Sung Pyo Park; Hum Chung; Bok-Ghee Han; Hyung-Lae Kim; Kuchan Kimm; Hyeong Gon Yu; Jong-Young Lee
Journal:  Mol Vis       Date:  2011-04-01       Impact factor: 2.367

3.  Mutation screening and haplotype analysis of the rhodopsin gene locus in Japanese patients with retinitis pigmentosa.

Authors:  Yuichiro Ando; Masayuki Ohmori; Hideki Ohtake; Kuniyo Ohtoko; Shigeru Toyama; Ron Usami; Aya O'hira; Hiromi Hata; Kenji Yanashima; Seishi Kato
Journal:  Mol Vis       Date:  2007-06-29       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.